184 related articles for article (PubMed ID: 2897300)
1. Comparison of the effects of two doses of bisoprolol on exercise tolerance in exercise-induced stable angina pectoris.
de Muinck E; Wagner G; vd Ven LL; Lie KI
Eur Heart J; 1987 Dec; 8 Suppl M():31-5. PubMed ID: 2897300
[TBL] [Abstract][Full Text] [Related]
2. A comparison of once daily bisoprolol, 5 and 10 mg, and atenolol 100 mg in the treatment of angina pectoris.
Maltz MB; Dymond DS; Nathan AW; Camm AJ
Eur Heart J; 1987 Dec; 8 Suppl M():37-42. PubMed ID: 2967184
[TBL] [Abstract][Full Text] [Related]
3. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
[TBL] [Abstract][Full Text] [Related]
4. Summary of short- and long-term studies with bisoprolol in coronary heart disease (CHD).
Wagner G
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S160-6. PubMed ID: 2439790
[TBL] [Abstract][Full Text] [Related]
5. Management of chronic stable angina with once-daily bisoprolol or atenolol and long-term efficacy of bisoprolol.
Kohli RS; Lahiri A; Raftery EB
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S148-53. PubMed ID: 2439787
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of once daily bisoprolol in stable angina pectoris: an objective comparison with atenolol and long term follow-up.
Kohli RS; Khurmi NS; Kardash MM; Hughes LO; Lahiri A; Raftery EB
Eur Heart J; 1985 Oct; 6(10):845-50. PubMed ID: 2866960
[TBL] [Abstract][Full Text] [Related]
7. Effects of a single oral administration of Epanolol on exercise tolerance in patients with stable effort angina pectoris.
Vandenbosch H; Piessens J; De Geest H
Acta Cardiol; 1991; 46(1):11-25. PubMed ID: 1674394
[TBL] [Abstract][Full Text] [Related]
8. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the safety and efficacy of bisoprolol versus atenolol in stable exercise-induced angina pectoris: a Multicenter International Randomized Study of Angina Pectoris (MIRSA).
de Muinck ED; Buchner-Moell D; van de Ven LL; Lie KI
J Cardiovasc Pharmacol; 1992 Jun; 19(6):870-5. PubMed ID: 1376806
[TBL] [Abstract][Full Text] [Related]
10. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
11. Effect of bisoprolol on cardiac performance in coronary heart disease.
Maisch B; Borst U; Gerhards W; Wagner G
Eur J Clin Pharmacol; 1989; 36(3):217-22. PubMed ID: 2568261
[TBL] [Abstract][Full Text] [Related]
12. [Effect of bisoprolol in coronary heart disease. Effect on cardiovascular parameters and ischemic ST depression: studies on the duration of the effect].
Prager G; Wagner G
Dtsch Med Wochenschr; 1984 Dec; 109(50):1914-7. PubMed ID: 6150839
[TBL] [Abstract][Full Text] [Related]
13. Comparison of once and twice daily oral dosing schedules of bevantolol, a new beta-adrenoceptor antagonist with alpha-adrenoceptor partial antagonist activity in patients with angina of effort.
Molajo AO; Bray CL; Hillier V
Int J Cardiol; 1989 Nov; 25(2):185-92. PubMed ID: 2572566
[TBL] [Abstract][Full Text] [Related]
14. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
[TBL] [Abstract][Full Text] [Related]
15. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
[TBL] [Abstract][Full Text] [Related]
16. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
Thadani U; Parker JO
Am J Cardiol; 1979 Jul; 44(1):118-25. PubMed ID: 377932
[TBL] [Abstract][Full Text] [Related]
17. Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
Thadani U; Davidson C; Singleton W; Taylor SH
Am J Med; 1980 Feb; 68(2):243-50. PubMed ID: 6101934
[TBL] [Abstract][Full Text] [Related]
18. Bisoprolol in the treatment of angina pectoris: a double blind comparison with verapamil.
De Divitiis O; Liguori V; Di Somma S; Brignoli M; Ferraro S; Petitto M; Fazio S; Marsullo G; Salvatore M; Gradnik R
Eur Heart J; 1987 Dec; 8 Suppl M():43-54. PubMed ID: 2967185
[TBL] [Abstract][Full Text] [Related]
19. The effects of a new adrenergic blocking agent (K4423) on exercise tolerance in angina pectoris.
Libretti A; Gregorini L; Valentini R
Cardiology; 1973; 58(6):369-75. PubMed ID: 4153721
[No Abstract] [Full Text] [Related]
20. Effect of bisoprolol on exercise tolerance in patients with coronary heart disease: placebo-controlled double-blind crossover study.
Schnellbacher K; Marsovszky E; Roskamm H
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S143-7. PubMed ID: 2439786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
